Zenas BioPharma, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Zenas BioPharma, Inc. (ZBIO) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $1.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-13
- Zenas BioPharma, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $1.05M.
- Zenas BioPharma, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $0.00.
- Zenas BioPharma, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-06-30 was $0.00.
- Zenas BioPharma, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-03-31 was $445.00K.
- Zenas BioPharma, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $1.50M, a 36.36% increase from fiscal 2024.
- Zenas BioPharma, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $1.10M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.05M derived: sum of 2 quarters · filed 2026-03-16 | $1.05M derived: sum of 3 quarters · filed 2026-08-13 | $1.50M 10-K · filed 2026-03-16 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $445.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $445.00K 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $445.00K 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | $1.10M 10-K · filed 2026-03-16 |